참고문헌
- Glover, D. M., Hagan, I. M. and Tavares, A. A. (1998) Polo-like kinases: a team that plays throughout mitosis. Genes. Dev. 12, 3777-3787. https://doi.org/10.1101/gad.12.24.3777
- Golsteyn, R. M., Schultz, S. J., Bartek, J., Ziemiecki, A., Ried, T. and Nigg, E. A. (1994) Cell cycle analysis and chromosomal localization of human Plk1, a putative homologue of the mitotic kinases Drosophila polo and Saccharomyces cerevisiae Cdc5. J. Cell Sci. 107, 1509-1517.
- Strebhardt, K. and Ullrich, A. (2006) Targeting polo-like kinase 1 for cancer therapy. Nat. Rev. Cancer 6, 321-330. https://doi.org/10.1038/nrc1841
- Chopra, P., Sethi, G., Dastidar, S. G. and Ray, A. (2010) Polo-like kinase inhibitors: an emerging opportunity for cancer therapeutics. Expert. Opin. Investig. Drugs 19, 27-43. https://doi.org/10.1517/13543780903483191
- Degenhardt, Y. and Lampkin, T. (2010) Targeting Polo-like kinase in cancer therapy. Clin. Cancer Res. 16, 384-389. https://doi.org/10.1158/1078-0432.CCR-09-1380
- Takai, N., Hamanaka, R., Yoshimatsu, J. and Miyakawa, I. (2005) Polo-like kinases (Plks) and cancer. Oncogene. 24, 287-291. https://doi.org/10.1038/sj.onc.1208272
- Knecht, R., Elez R., Oechler, M., Solbach, C., von Ilberg, C. and Strebhardt, K. (1999) Prognostic significance of polo-like kinase (PLK) expression in squamous cell carcinomas of the head and neck. Cancer Res. 59, 2794-2797.
- Spankuch-Schmitt, B., Bereiter-Hahn, J., Kaufmann, M., and Strebhardt, K. (2002) Effect of RNA silencing of polo-like kinase-1 (PLK1) on apoptosis and spindle formation in human cancer cells. J. Natl. Cancer Inst. 94, 1863-1877. https://doi.org/10.1093/jnci/94.24.1863
- Rizki, A., Mott, J. D. and Bissell, M. J. (2007) Polo-like kinase 1 is involved in invasion through extracellular matrix. Cancer Res. 67, 11106-11110. https://doi.org/10.1158/0008-5472.CAN-07-2348
- Liu, X. and Erikson, R. L. (2003) Polo-like kinase (Plk)1 depletion induces apoptosis in cancer cells. Proc. Natl. Acad. Sci. U.S.A. 100, 5789-5794. https://doi.org/10.1073/pnas.1031523100
- Reagan-Shaw, S. and Ahmad, N. (2005) Silencing of polo-like kinase (Plk) 1 via siRNA causes induction of apoptosis and impairment of mitosis machinery in human prostate cancer cells: implications for the treatment of prostate cancer. FASEB J. 19, 611-613. https://doi.org/10.1096/fj.04-2910fje
- Liu, X., Lei, M. and Erikson, R. L. (2006) Normal cells, but not cancer cells, survive severe Plk1 depletion. Mol. Cell Biol. 26, 2093-2108. https://doi.org/10.1128/MCB.26.6.2093-2108.2006
- Bumcrot, D., Manoharan, M., Koteliansky, V. and Sah, D. W. (2006) RNAi therapeutics: a potential new class of pharmaceutical drugs. Nat. Chem. Biol. 2, 711-719. https://doi.org/10.1038/nchembio839
- Tiemann, K. and Rossi, J. J. (2009) RNAi-based therapeutics-current status, challenges and prospects. EMBO Mol. Med. 1, 142-151. https://doi.org/10.1002/emmm.200900023
- Bu, Y., Yang, Z., Li, Q. and Song, F. (2008) Silencing of polo-like kinase (Plk) 1 via siRNA causes inhibition of growth and induction of apoptosis in human esophageal cancer cells. Oncology 74, 198-206. https://doi.org/10.1159/000151367
- Marioni, G., Marchese-Ragona, R., Cartei, G., Marchese, F. and Staffieri, A. (2006) Current opinion in diagnosis and treatment of laryngeal carcinoma. Cancer Treat. Rev. 32, 504-515. https://doi.org/10.1016/j.ctrv.2006.07.002
- Papadas, T. A., Alexopoulos, E. C., Mallis, A., Jelastopulu, E., Mastronikolis, N. S. and Goumas, P. (2010) Survival after laryngectomy: a review of 133 patients with laryngeal carcinoma. Eur. Arch. Otorhinolaryngol. 267, 1095-1101. https://doi.org/10.1007/s00405-009-1156-8
- Juan, G., Traganos, F., James, W. M., Ray, J. M., Roberge, M., Sauve, D. M., Anderson, H. and Darzynkiewicz, Z. (1998) Histone H3 phosphorylation and expression of cyclins A and B1 measured in individual cells during their progression through G2 and mitosis. Cytometry 32, 71-77. https://doi.org/10.1002/(SICI)1097-0320(19980601)32:2<71::AID-CYTO1>3.0.CO;2-H
- Tilesi, F., Fradiani, P., Socci, V., Willems, D. and Ascenzioni, F. (2009) Design and validation of siRNAs and shRNAs. Curr. Opin. Mol. Ther. 11, 156-164.
- Huesken, D., Lange, J., Mickanin, C., Weiler, J., Asselbergs, F., Warner, J., Meloon, B., Engel, S., Rosenberg, A., Cohen, D., Labow, M., Reinhardt, M., Natt, F. and Hall, J. (2005) Design of a genome-wide siRNA library using an artificial neural network. Nat. Biotechnol. 23, 995-1001. https://doi.org/10.1038/nbt1118
- Hung, C. F., Lu, K. C., Cheng, T. L., Wu, R. H., Huang, L. Y., Teng, C. F. and Chang, W. T. (2006) A novel siRNA validation system for functional screening and identification of effective RNAi probes in mammalian cells. Biochem. Biophys. Res. Commun. 346, 707-720. https://doi.org/10.1016/j.bbrc.2006.05.164
- Luo, Q., Kang, Q., Song, W. X., Luu, H. H., Luo, X., An, N., Luo, J., Deng, Z. L., Jiang, W., Yin, H., Chen, J., Sharff, K. A., Tang, N., Bennett, E., Haydon, R. C. and He, T. C. (2007) Selection and validation of optimal siRNA target sites for RNAi-mediated gene silencing. Gene 395, 160-169. https://doi.org/10.1016/j.gene.2007.02.030
- Liu, X. and Erikson, R. L. (2002) Activation of Cdc2/cyclin B and inhibition of centrosome amplification in cells depleted of Plk1 by siRNA. Proc. Natl. Acad. Sci. U.S.A. 99, 8672-8676. https://doi.org/10.1073/pnas.132269599
- Roshak, A. K., Capper, E. A., Imburgia, C., Fornwald, J., Scott, G. and Marshall, L. A. (2000) The human polo-like kinase, PLK, regulates cdc2/cyclin B through phosphorylation and activation of the cdc25C phosphatase. Cell Signal 12, 405-411. https://doi.org/10.1016/S0898-6568(00)00080-2
- Yamada, S., Ohira, M., Horie, H., Ando, K., Takayasu, H., Suzuki, Y., Sugano, S., Hirata, T., Goto, T., Matsunaga, T., Hiyama, E., Hayashi, Y., Ando, H., Suita, S., Kaneko, M., Sasaki, F., Hashizume, K., Ohnuma, N. and Nakagawara, A. (2004) Expression profiling and differential screening between hepatoblastomas and the corresponding normal livers: identification of high expression of the PLK1 oncogene as a poor-prognostic indicator of hepatoblastomas. Oncogene 23, 5901-5911. https://doi.org/10.1038/sj.onc.1207782
- Livak, K. J. and Schmittgen, T. D. (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25, 402-408. https://doi.org/10.1006/meth.2001.1262
피인용 문헌
- Clinicopathological significance of Polo-like kinase 1 (PLK1) expression in human malignant glioma vol.114, pp.5, 2012, https://doi.org/10.1016/j.acthis.2011.09.004
- High expression of polo-like kinase 1 is associated with the metastasis and recurrence in urothelial carcinoma of bladder vol.31, pp.7, 2013, https://doi.org/10.1016/j.urolonc.2011.11.028